IRVINE, Calif., February 13, 2018 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the initiation of research coverage on Novus Therapeutics, Inc. (NasdaqCM: NVUS) of Irvine, California. For a copy of the initiation report, please click here.